Montigny le Bretonneux, France

Nicolas Pietrancosta

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Sorbonne Université. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Pietrancosta. Retrieved from https://idiyas.com/inventor/nicolas-pietrancosta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nicolas Pietrancosta

Introduction

Nicolas Pietrancosta is an accomplished inventor based in Montigny le Bretonneux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mood-related disorders. His innovative work focuses on the development of selective organic cation transporters inhibitors.

Latest Patents

Nicolas Pietrancosta holds a patent for "Selective organic cation transporters inhibitors for the treatment of depressive disorders." This patent discloses organic cation transporters (OCTs) inhibitors of Formula (A), along with their pharmaceutically acceptable tautomers, salts, or solvates. The patent also includes pharmaceutical compositions that utilize these OCTs inhibitors for treating and preventing mood-related disorders, such as depressive disorders.

Career Highlights

Throughout his career, Nicolas has worked with prestigious institutions, including Sorbonne Université and the Centre National de la Recherche Scientifique. His research has focused on developing innovative solutions to address mental health challenges.

Collaborations

Nicolas has collaborated with notable colleagues, including Sophie Gautron and Francine Acher. Their combined expertise has contributed to advancements in the field of pharmacology.

Conclusion

Nicolas Pietrancosta's work exemplifies the impact of innovation in the treatment of depressive disorders. His contributions to the field through his patent and collaborations highlight the importance of research in improving mental health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…